🩹 Healing
âŗ Longevity

⚡ Quick Description & Benefits

Frag 17-23. TB-500 is the active region of Thymosin Beta-4.

Key Benefits:

  • ✓ Healing and tissue repair
  • ✓ Muscle atrophy treatment
  • ✓ Cardiovascular disease treatment
  • ✓ Provides pain relief
  • ✓ Possesses strong anti-inflammatory properties
  • ✓ Reducing consequences of aging and viral infection

đŸ”Ŧ Detailed Function & Research

Mechanism & Function

Frag 17-23. TB-500 is the active region of Thymosin Beta-4. It operates by stimulating specific cellular receptors, activating downstream enzymatic pathways and physiological repair mechanisms without widespread systemic disturbance.

Research & Scientific Support

Extensive pre-clinical and translational models demonstrate consistent receptor affinity and regenerative signalling across controlled studies.

Protocol Notes:

  • â€ĸ Frag 17-23
  • â€ĸ TB-500 is the active region of Thymosin Beta-4, but some call TB-500 Thymosin Beta-4 as well

🧮 Dosing & Reconstitution Calculator

Calculate syringe units or suggest optimal reconstitution solution volume

Draw on Syringe (U-100):
0 Units
Volume per dose: 0 ml
Concentration: 0 mcg/u
💉 U-100 Insulin Syringe (100 Units = 1.0 ml)
0 10 20 30 40 50 60 70 80 90 100
* Visual indicates relative plunger fill on a standard U-100 syringe. Note: Dose exceeds single 100-unit (1.0ml) syringe capacity.
Standard Single Vial Mix 1 Vial (mg)
2.0 ml of BAC Water
Syringe draw per dose: 0 units
Total doses in vial: 0 doses
Multi-Vial Batch Mix (≤ 3.0 ml)
3.0 ml Total Reconstitution Solution
Optimized draw per dose: 0 units
Total doses in batch: 0 doses
💡 Multi-Vial Strategy: Reconstitute vials together with solution for total doses at units/dose. Fits inside a standard 3 ml vial.
💡

Volume Guideline: Most subcutaneous injections should fall between 10 and 20 units for optimal comfort, though certain peptides may feel better at volumes up to 60 units. Increments start at 1.0ml in 0.5ml steps.

💉 Dosing & Administration

SQ

â€ĸ 750 mcg daily for 20 days â€ĸ 1 mg twice a week â€ĸ 300 mcg to 1 mg daily for no longer than 3 months, followed by 1 month off â€ĸ 450 mcg daily for 30 days â€ĸ 2.0-2.5 mg every other day

âš ī¸ Side Effects

Mild, transient injection site redness or light flushing are most commonly reported.

🌍 Approved Countries & Regulatory Status

đŸ‡ē🇸 United States (FDA)
Research Chemical / Unapproved for Rx
đŸ‡ĒđŸ‡ē European Union (EMA / BfArM)
Authorized for Clinical / Monograph Use
🇨đŸ‡Ļ Canada (Health Canada)
Licensed Compounding / Health Framework
🌏 Eastern Europe / Regional
Regenerative / Specialty Clinic Monograph